Accendra Health, Inc.
ACHHealthcareNASDAQMedical Distribution · Last scanned Jul 22, 2026
Scan Results
Daily timeframeAccendra Health, Inc., together with its subsidiaries, operates as a healthcare solutions company in the United States. With a market capitalization of $261.9M, it sits in micro-cap territory. It offers a range of products and services for in-home care and delivery for diabetes treatment; home respiratory therapy, including home oxygen and non-invasive ventilation services; obstructive sleep apnea treatment, such as continuous positive airway pressure and bi-level positive airway pressure devices, and patient support services.
Market Cap
$261.9M
Beta
1.58
P/E (TTM)
—
P/E (Fwd)
4.97
EPS (TTM)
$-1.41
EPS (Fwd)
$0.69
ROE
-198.3%
ROA
1.6%
Cash
$338.5M
Total Debt
$2.17B
Free CF
$650.3M
52W Change
-57.8%
Annual Financials
Cash vs Debt
Where ACH stands vs its 150-day and 200-day moving averages
As of the July 15, 2026 close, ACH finished 30.32% above its 150-day moving average ($2.77) and 17.97% above its 200-day moving average ($3.06). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.
Is ACH overbought or oversold?
At the July 15, 2026 close, ACH's RSI(14) was 64.6, in neutral territory (between 30 and 70). The MACD histogram was positive, so short-term momentum leaned bullish at that close. These readings are historical, refresh daily after market close, and are not investment advice.
Accendra Health, Inc. carries $2.17B in total debt against $338.5M in cash reserves — debt is roughly 6.4x the cash position. Managing this leverage effectively will be important for long-term financial stability. The company generates $650.3M in free cash flow annually, which funds everything from R&D to shareholder returns without needing external financing. ROE of -198.3% points to negative capital efficiency, indicating how much profit the company produces per dollar of shareholder equity. ROA of 1.6% is on the lower side, which is common in asset-heavy industries. Revenue has been uneven over recent years, ranging from $9.96B to $2.76B.
With a beta above 1.5, ACH tends to amplify broader market moves — both up and down. This higher volatility means larger price swings are common. Accendra Health, Inc. carries a heavier debt load relative to its cash position, which introduces financial risk that investors should weigh. These risk factors are not exhaustive — macroeconomic shifts, regulatory changes, and competitive dynamics can all influence Accendra Health, Inc.'s trajectory.